Evonik Industries AG (EVKd)
FRA • Basic Materials
October 27, 2026 at 13:02 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every €100 in revenue, Evonik Industries AG keeps €2 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Evonik Industries’ adjusted EPS topped expectations while revenue came in line, as the group grew sales year over year but saw profit fall in the second fiscal quarter of 2026 reported on August 4, 2026. Revenue rose 11.3% to about €3.9 billion (up from €3.499 billion a year ago), with the consensus comparison showing revenue of €3.893 billion versus an estimate of €3.817 billion (+2.0%, in line). Adjusted EPS of €0.64 topped the €0.55 estimate (+18%), while net income fell 30.0% to roughly €84 million (down from €120.0 million a year ago). Profitability for the quarter included gross profit of about €962 million with gross margin near 25%, and operating income of roughly €483 million as operating margin stood around 12%. Evonik generated operating cash flow of about €204 million. For the next period, consensus calls for EPS of €0.49 on revenue of €3.643 billion.
Next report — what to expect
Evonik Industries AG (EVK.DE) reports earnings on November 3, 2026. Wall Street expects EPS of EUR 0.523 on revenue of EUR 3.62 billion. For trailing context, revenue rose +11.3% year over year last quarter. Evonik has beaten EPS in 5 of 8 most recent quarters, so traders may focus on how results compare with consensus.
About Evonik Industries AG
Evonik Industries AG operates in specialty chemicals and materials and is listed on XETRA under EVK.DE. The company makes additives, intermediates, polymers, and performance chemicals used across consumer, industrial, health, and mobility markets, and generated EUR 14.1 billion in FY2025 revenue.
Today's Snapshot
EVKd is trading 0.7% lower at 21.16. So far today, EVKd is within 3.1% of its 52-week high of 21.84. BASF, a chemical maker, raised its offer to buy Evonik to more than €11 billion.
Trading Volume
Below 10d avg (1.2M)
61.5K
vs S&P 500 Today
Underperforming Market
-1.36%
Updated: October 27, 2026 at 11:37 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$17.07 - $21.08Buy
- RSI (14)61.96Neutral
- Stochastic %K (14, 3, 3)66.67Neutral
- MACD Level (12, 26)0.54Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.